Literature DB >> 10986338

Facilitation by P(2) receptor activation of acetylcholine release from rat motor nerve terminals: interaction with presynaptic nicotinic receptors.

A I Salgado1, R A Cunha, J A Ribeiro.   

Abstract

ATP is released from motor nerve endings together with acetylcholine. Released adenine nucleotides can be extracellularly metabolized into adenosine, which is a presynaptic neuromodulator at neuromuscular junctions, but it is not known if P(2) receptor activation also modulates acetylcholine release from mature motor nerve endings. We now tested the effect of a stable ATP analogue, beta,gamma-imido ATP on the nerve-evoked release of acetylcholine from adult rat hemidiaphragm preparations. beta,gamma-Imido ATP (10-100 microM) facilitated in a concentration-dependent manner evoked acetylcholine release, and 30 microM beta,gamma-imido ATP caused a 125% facilitation of evoked acetylcholine release. This facilitatory effect of beta,gamma-imido ATP (30 microM) was abolished by the P(2) receptor antagonists, suramin (100 microM) and pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid (PPADS, 10 microM), but not by the A(1) or A(2A) adenosine receptor antagonists, 1,3-dipropyl-8-cyclopentylxanthine (50 nM) and ZM 241385 (50 nM), respectively. The facilitation of acetylcholine release by beta, gamma-imido ATP (30 microM) was also prevented by the nicotinic acetylcholine receptor antagonist, D-tubocurarine (1 microM) and the facilitatory effect (40%) of the nicotinic acetylcholine receptor agonist, 1,1-dimethyl-4-phenylpiperazinium (1 microM) was abolished by PPADS (10 microM). These results demonstrate a presynaptic facilitatory effect of P(2) receptor activation at the rat phrenic nerve endings, which is tightly coupled with the presynaptic nicotinic autofacilitatory system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986338     DOI: 10.1016/s0006-8993(00)02679-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems.

Authors:  S A Deuchars; L Atkinson; R E Brooke; H Musa; C J Milligan; T F Batten; N J Buckley; S H Parson; J Deuchars
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

2.  Ecto-AMP deaminase blunts the ATP-derived adenosine A2A receptor facilitation of acetylcholine release at rat motor nerve endings.

Authors:  M Teresa Magalhães-Cardoso; M Fátima Pereira; Laura Oliveira; J A Ribeiro; Rodrigo A Cunha; Paulo Correia-de-Sá
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

Review 3.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

4.  Adenosine A2B and A3 receptor location at the mouse neuromuscular junction.

Authors:  Neus Garcia; Mercedes Priego; Erica Hurtado; Teresa Obis; Manel M Santafe; Marta Tomàs; Maria Angel Lanuza; Josep Tomàs
Journal:  J Anat       Date:  2014-04-23       Impact factor: 2.610

5.  Interaction between P2X and nicotinic acetylcholine receptors in glutamate nerve terminals of the rat hippocampus.

Authors:  Ricardo J Rodrigues; Teresa Almeida; Alexandre de Mendonça; Rodrigo A Cunha
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

6.  The mechanism by which ethanol inhibits rat P2X4 receptors is altered by mutation of histidine 241.

Authors:  Keming Xiong; Xiang-Qun Hu; Randall R Stewart; Forrest F Weight; Chaoying Li
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

7.  P2 receptor-mediated modulation of neurotransmitter release-an update.

Authors:  Beáta Sperlágh; Attila Heinrich; Cecilia Csölle
Journal:  Purinergic Signal       Date:  2007-10-09       Impact factor: 3.765

Review 8.  Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.

Authors:  Júlia Leão Batista Simões; Julia Beatrice de Araújo; Margarete Dulce Bagatini
Journal:  Mol Neurobiol       Date:  2021-07-11       Impact factor: 5.590

9.  Adenosine Receptors in Developing and Adult Mouse Neuromuscular Junctions and Functional Links With Other Metabotropic Receptor Pathways.

Authors:  Josep Tomàs; Neus Garcia; Maria A Lanuza; Manel M Santafé; Marta Tomàs; Laura Nadal; Erica Hurtado; Anna Simó-Ollé; Víctor Cilleros-Mañé; Laia Just-Borràs
Journal:  Front Pharmacol       Date:  2018-04-24       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.